Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
TRI LOCUM PARTNERS LP | 02-14-2024 | 12-31-2023 | 24 | 218,758,977 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
AMGEN INC | COM | Liquidated | $0 | 0 | 0.01 | 107,480 | +Inf | 12-31-2023 | |
ABBVIE INC | COM | 2 | $26,005,051 | 167,807 | 0.01 | 0.01 | 23,246 | 16.08 | 12-31-2023 |
DEXCOM INC | COM | Liquidated | $0 | 0 | 0.01 | 0.00 | 215,582 | 416.20 | 12-31-2023 |
SPDR S&P 500 ETF TR | TR UNIT | Liquidated | $0 | 0 | 0.01 | 45,208 | +Inf | 12-31-2023 |